Sarah B. Goldberg, MD, MPH, assistant professor of medicine, Yale School of Medicine and Yale Cancer Center, discusses the diagnosis of mesothelioma. This is an extremely rare disease that is usually seen in patients with prior asbestos exposure, Goldberg says. However, mesothelioma can be seen … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Mesothelin-Targeted CAR T-Cell Therapy Shows Early Efficacy in Advanced Solid Cancers
… Malignant pleural mesothelioma is an aggressive solid tumor that arises either as a primary tumor or as metastatic disease secondary to lung or breast cancer. The disease has a poor prognosis, and the FDA has not approved a new treatment for malignant pleural mesothelioma since 2003, Adusumilli … More
Johnson & Johnson Settles Oklahoma Talc-Cancer Case
Johnson & Johnson reached a confidential settlement resolving an Oklahoma lawsuit alleging its iconic baby powder caused a 77-year-old woman to develop a rare cancer connected to asbestos exposure. The accord comes the same day the company was cleared by a New Jersey jury of a similar claim … More
Breast Implants FDA March 2019 Meeting: Lymphoma Cancer Was A Main Topic
There was an FDA CDRH General and Plastic Surgery Devices Advisory Committee Meeting held on March 25-26, 2019. The first day was focused in large part on Breast Implant Associated Anaplastic Large-Cell Lymphoma (BIA-ALCL). This lymphoma cancer associated with breast implants is a rare type of blood … More
Contrast Agents And Gadolinium Deposition Disease: Medical Literature Review, September 2018 – February 2019
We continue to monitor the medical literature for developments related to gadolinium retention in connection with our investigation of cases of Gadolinium Deposition Disease (GDD) in patients who received injections of gadolinium based contrast agents for their MRI, MRA, or CT scan … More
Johnson & Johnson must pay dying woman $29 million over talc-linked cancer
Johnson & Johnson must pay about $29 million to a dying California woman who blamed asbestos-tainted talc for causing her cancer, the company’s latest loss in nationwide litigation over its iconic baby powder. Jurors in state court in Oakland, Calif., Wednesday held J&J responsible for … More